InspireMD, Inc. NSPR revenue by segment, product and geography
In its fiscal year ending 2025-12-31, InspireMD, Inc. reported revenue across 5 geographies; the largest, Other countries, was $4.06M, 45.2% of the filed sum (+18.7% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Other countries$4.06M45.2%+18.7% yoy
- United States$1.42M15.8%+4328.1% yoy
- Germany$1.23M13.7%+33.2% yoy
- Italy$1.23M13.7%+0.7% yoy
- PL$1.04M11.5%+49.3% yoy
Members sum to the consolidated $8.98M for this period.
- Other countries$1.31M38.6%+69.7% yoy
- United States$1.18M34.7%+4263.0% yoy
- Italy$354K10.4%+35.1% yoy
- PL$301K8.9%+33.2% yoy
- Germany$255K7.5%+5.4% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.